Mehrdad Rakaee

8PUBLICATIONS

107CO-AUTHORS

Molecular targetsInnate immunityPredictive and prognostic markersTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 18, 2026

Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|Dec 19, 2025

Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer.

Amin H Nassar, Elias Bou Farhat, Hassan Abushukair

|Oct 06, 2025

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Bernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio

|Aug 19, 2025

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.

Amin H Nassar, Chul Kim, Tolulope Adeyelu

|Feb 08, 2024

Association of Baseline Tumor-Specific Neoantigens and CD8<sup>+</sup> T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.

Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti

|Apr 25, 2023

Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.

Biagio Ricciuti, Arielle Elkrief, Joao Alessi

Pageof 2

Frequent Collaborators

Biagio Ricciuti

Joao V Alessi

Amin H Nassar

Mark M Awad

Arielle Elkrief

Xinan Wang

Lynette M Sholl

Federica Pecci

Mizuki Nishino

Alessandro Di Federico

Frequent Collaborators

Biagio Ricciuti

Joao V Alessi

Amin H Nassar

Mark M Awad